TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
MDRX

Veradigm Inc.

Healthcare · Health Information Services

5.10$ +1.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Veradigm Inc. (MDRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2024), "Operating Cash Flow" came in at 116 million $. Tick rows to compare them in a chart.

Tick rows to compare them in a chart (up to 4)

Cash Flow MDRX
Line item 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2024
-4.2 -13 -25 -33 -11 5.2 12 17 27 36 36 140 140 269 223 81 103 212 269 279 68 46 -107 -75 116 116
1.5 2.5 29 68 5.6 4.9 5.0 6.5 16 23 23 37 37 132 150 179 174 161 172 219 192 230 87 73 116 116
– – – 0.5 0.3 0.3 0.4 0.6 2.3 5.8 5.8 15 15 41 39 37 39 35 43 39 35 39 11 12 25 25
– – – – – – – – – – – – – 79 36 1.1 46 35 39 151 -77 6.7 -110 -370 – –
-0.8 -1.5 -8.9 -1.3 -2.8 4.7 3.9 -0.9 -13 -35 -35 -7.0 -7.0 -6.1 37 4.1 -50 16 54 58 -60 -18 -152 -24 24 24
0.8 4.4 9.4 3.6 1.7 0.7 5.6 2.0 15 19 19 35 35 105 123 116 67 68 138 157 145 128 17 1.9 32 32
-0.8 -12 -47 -9.3 -7.9 -9.5 -81 18 -180 -262 – – -32 -96 -123 -252 -109 -289 -1,154 -413 248 -161 1,615 -12 – 585
– – – – – – – – – – – 43 – 47 324 0.0 0.0 0.0 1,157 375 580 – – – – –
– -35 – – – – -11 – -21 -52 -52 -52 -670 -51 -226 0.0 0.0 0.0 -121 -12 -139 -111 -334 -417 -234 -234
– – – – – – – – – – – – – -125 72 75 4.6 45 660 220 -283 272 -764 175 -178 –
5.6 65 108 -0.2 1.8 0.3 72 9.4 134 297 297 -36 -36 -144 -155 132 -4.3 142 865 199 -293 67 -1,110 -259 -445 -445
0.6 40 36 -42 -17 -3.9 3.6 44 -18 71 71 72 72 28 -54 -41 -9.8 64 -20 66 22 -47 400 -347 256 256
-5.0 -17 -34 -37 -12 4.5 7.0 15 13 17 17 105 105 164 100 -35 36 144 131 122 -77 -84 -124 -79 83 83

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?